VTE in cancer patients
Showing 1 - 25 of >10,000
Compare Health Care Costs Between Apixaban and Low Molecular
Active, not recruiting
- Thromboembolism
-
New York, New YorkPfizer Investigational
Dec 1, 2022
Deep Vein Thrombosis, Pulmonary Embolus, Colon Cancer Trial (Colon resection)
Completed
- Deep Vein Thrombosis, Pulmonary Embolus
- Colon Cancer
- Colon resection
- (no location specified)
Aug 18, 2023
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Detroit (Abelacimab, Dalteparin)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Dalteparin
-
Detroit, MichiganHenry Ford Health System
Jul 18, 2022
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Canada, United States (Abelacimab, Apixaban)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Apixaban
-
Lexington, Kentucky
- +2 more
Jun 6, 2022
Anticoagulation in Venous Thromboembolism and Cancer
Active, not recruiting
- Neoplasms
- Embolism
- Apixaban
- +5 more
-
London, United KingdomPfizer Investigational Site
Nov 17, 2022
Venous Thromboembolism, Urologic Cancer Trial (Rivaroxaban 10 MG, Placebo control)
Not yet recruiting
- Venous Thromboembolism
- Urologic Cancer
- Rivaroxaban 10 MG
- Placebo control
- (no location specified)
Jun 16, 2023
Cancer Patients With Acute Lower Limb Deep Vein Thrombosis (DVT) Trial in Shanghai (mechanical thrombectomy (PMT))
Not yet recruiting
- Cancer Patients With Acute Lower Limb Deep Vein Thrombosis (DVT)
- mechanical thrombectomy (PMT)
-
Shanghai, Shanghai, ChinaRenji Hospital
Oct 10, 2023
Gather Information How Often Venous Thromboembolism Occurs in
Completed
- Venous Thromboembolism (VTE)
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Multiple Locations, SwedenMany Locations
Nov 24, 2021
Intracranial Hemorrhage in Glioma Venous Thromboembolism
Terminated
- Glioma, Malignant
- Observation of ICH and VTE
-
Sacramento, California
- +1 more
Aug 5, 2022
Venous Thromboembolic Disease, Pulmonary Embolism, Deep Venous Thrombosis Trial (Bleeding-risk based prophylaxis strategy during
Not yet recruiting
- Venous Thromboembolic Disease
- +2 more
- Bleeding-risk based prophylaxis strategy during hospitalization and extended pharmacological treatment after discharge
- Routine VTE prophylaxis in hospital
- (no location specified)
Aug 1, 2021
Venous Thromboembolism, Cancer Trial in Aachen (Rivaroxaban, low-molecular heparine)
Terminated
- Venous Thromboembolism
- Cancer
- Rivaroxaban
- low-molecular heparine
-
Aachen, GermanyUniklinik
Apr 28, 2021
Rate of Perioperiative VTE in Colorectal Cancer Patients
Unknown status
- Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients
- (no location specified)
Oct 9, 2020
Venous Thromboembolic Disease, Respiratory Disease, Pulmonary Disease Trial in Spain (Fludeoxyglucose 18F)
Recruiting
- Venous Thromboembolic Disease
- +6 more
- Fludeoxyglucose 18F
-
Badalona, Barcelona, Spain
- +16 more
Nov 25, 2021
Venous Thromboembolism in Primary Pancreatic Tumour Resection
Not yet recruiting
- Venous Thromboembolism
- +2 more
-
Larissa, Thessaly, GreeceUniversity Hospital of Larissa
Jul 27, 2023
Asymptomatic PICC-Related Thrombosis in Solid Cancer Patients
Completed
- Catheter Related Complication
- Doppler Ultrasound
-
Verona, ItalyAzienda Ospedaliera Universitaria Integrata
Aug 1, 2023
Gather Information About Rivaroxaban in Sweden With Cancer Who
Active, not recruiting
- Treatment of Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +3 more
-
Multiple Locations, Many Locations, SwedenSwedish registries
Aug 18, 2022
Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT) Trial in Worldwide (Edoxaban, Standard of Care)
Completed
- Venous Thromboembolism (VTE)
- +2 more
- Edoxaban
- Standard of Care
-
Tucson, Arizona
- +139 more
Jun 28, 2022
Venous Thromboembolism in Hematologic Malignancy and
Active, not recruiting
- Thrombosis, Venous
- +4 more
-
Toronto, Ontario, CanadaFederico Carini
Nov 21, 2022
Colorectal Cancer Metastatic, Thromboembolism Trial in Spain (Tinzaparin)
Not yet recruiting
- Colorectal Cancer Metastatic
- Thromboembolism
-
Santiago De Compostela, A Coruña, Spain
- +32 more
Nov 23, 2022
Cancer-associated Thrombosis Trial in Worldwide (Apixaban 5 MG)
Recruiting
- Cancer-associated Thrombosis
- Apixaban 5 MG
-
Graz, Austria
- +112 more
Dec 7, 2022
Venous Thromboembolism and Prevention of Recurrent VTE in Active
Completed
- Venous Thrombosis and Pulmonary Embolism
- Rivaroxaban (Xarelto, BAY 59-7939)
-
Multiple Locations, Australia
- +9 more
Feb 10, 2020
Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban
Active, not recruiting
- Treatment of Venous Thromboembolism in Cancer Patients
- +2 more
- Rivaroxaban (Xarelto, BAY59-7939)
- Apixaban
-
Wuppertal, GermanyBayer
Jul 25, 2022
Thromboembolism of Vein VTE in Colorectal Cancer, Thromboembolism of Vein in Pancreatic Cancer, Thromboembolism of Vein in NSCLC
Completed
- Thromboembolism of Vein VTE in Colorectal Cancer
- +2 more
-
Los Angeles, California
- +10 more
Feb 11, 2021
Venous Thromboembolism, Lung Tumor Trial in France (Tinzaparin Sodium)
Terminated
- Venous Thromboembolism
- Lung Neoplasm
- Tinzaparin Sodium
-
Rennes, Bretagne, France
- +26 more
Nov 14, 2022
Thromboembolism in Cancer Patients: Experience atComprehensive
Completed
- Cancer
- +3 more
- Retrospective Chart Review
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 22, 2022